The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported symptom burden in relapsed or refractory multiple myeloma.
 
Loretta A. Williams
Consulting or Advisory Role - PledPharma
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bayer; Bristol-Myers Squibb; Genentech
 
Xin Shelley Wang
Research Funding - Bristol-Myers Squibb
 
Qiuling Shi
Consulting or Advisory Role - Amgen/Dompé
 
Huei-Kai Lin
No Relationships to Disclose
 
Araceli Garcia-Gonzalez
No Relationships to Disclose
 
Catherine C. Davis
Employment - Bristol-Myers Squibb
 
Charles S. Cleeland
Honoraria - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Merck Sharp & Dohme; Novartis; Onconova Therapeutics; Pfizer
Research Funding - Bayer (Inst); Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Bayer License agreement to use the MDASI (M D Anderson Symptom Inventory) (Inst)
Travel, Accommodations, Expenses - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer
 
Robert Z. Orlowski
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; FORMA Therapeutics; Incyte
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene
 
Teresa Maria Zyczynski
Employment - Bristol-Myers Squibb